Hong Kong - Neostigmine Methylsulphate injection

This is a business opportunity from an overseas buyer. Pitch for the business and explain how your company meets their requirements.

A tender has been issued by a local authority for the supply of Neostigmine Methylsulphate injection.

Details

Opportunity closing date
24 February 2025
Opportunity publication date
09 January 2025
Opportunity type
Public Sector
Industry
Healthcare services
Enquiries received
1
Value of contract
to be confirmed
Your guide to exporting
Report opportunity

Description

You must be able to:

 - Supply a minimum quantity of 105,000 ampoules of Neostigmine Methylsulphate

 injection 2.5mg in 1ml, preservative-free

Packaging requirements:

 - immediate container and all levels of packaging of the actual sales pack must include an English translation

 - the expiration date must be expressed in English and/or Arabic numerals in a clear and  comprehensible format

A 3 year contract with a possible extension of up to 24 months.

You must be:

·       a UK registered company

Opportunity closing date

24 February 2025, 12:00 pm (Hong Kong Time)

Opportunity closing date
24 February 2025
Value of contract
to be confirmed
The buyer is happy to talk to
manufacturers, wholesalers, distributors, agents

The deadline to apply for this opportunity has passed.
Visit the opportunities page to find another.

Is there anything wrong with this page?